(Q35826295)

10 August 2017

1 reference

title

Budesonide/formoterol: a review of its use in asthma (English)

1 reference

10 August 2017

0 references

budesonide/formoterol

1 reference

2

Gillian M Keating

1 reference

10 August 2017

David R Goldsmith

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

64

1 reference

10 August 2017

issue

14

1 reference

10 August 2017

page(s)

1597-1618

1 reference

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

10 August 2017

cites work

1 reference

12 December 2020

Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months.

1 reference

12 December 2020

Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults

1 reference

12 December 2020

Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma

1 reference

12 December 2020

Lung deposition of budesonide from turbuhaler in asthmatic children

1 reference

12 December 2020

Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide

1 reference

12 December 2020

Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data

1 reference

12 December 2020

Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma

1 reference

12 December 2020

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma

1 reference

12 December 2020

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

1 reference

12 December 2020

The role of inflammation and anti-inflammatory medication in asthma

1 reference

12 December 2020

One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma

1 reference

12 December 2020

Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma

1 reference

12 December 2020

Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients

1 reference

12 December 2020

Inhaled budesonide/formoterol combination

1 reference

12 December 2020

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

1 reference

12 December 2020

Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid

1 reference

12 December 2020

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

1 reference

12 December 2020

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction

1 reference

12 December 2020

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

12 December 2020

Clinical pharmacokinetics of inhaled budesonide

1 reference

12 December 2020

Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study

1 reference

12 December 2020

Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma

1 reference

12 December 2020

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers

1 reference

12 December 2020

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

1 reference

12 December 2020

Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma

1 reference

12 December 2020

Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study

1 reference

12 December 2020

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

12 December 2020

Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing.

1 reference

12 December 2020

Managing a variable disease

1 reference

12 December 2020

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

12 December 2020

Combined budesonide/formoterol turbuhaler treatment of asthma

1 reference

12 December 2020

An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing.

1 reference

12 December 2020

Symbicort Turbuhaler: a new concept in asthma management.

1 reference

12 December 2020

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

1 reference

12 December 2020

Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma.

1 reference

12 December 2020

Pharmacological factors that influence the choice of inhaled corticosteroids

1 reference

12 December 2020

Symbicort: controlling asthma in adults

1 reference

12 December 2020

Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler

1 reference

12 December 2020

10.2165/00003495-200464140-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1039250703

0 references

1 reference